Yale University
This is an open label, exploratory pilot study that will assess the effects of dual site focused pulsed ultrasound treatment on glycemic parameters in subjects with T2DM.
This study will test whether multi-site abdominal ultrasound stimulation can have lasting effects on elevated glucose levels in patients with diabetes.
Inclusion Criteria: 1. Male or female subjects with a diagnosis of type 2 diabetes ≥ 3 months. 2. Age ≥ 21 and ≤ 75 years. 3. Currently on a stable treatment regimen of oral anti-diabetic drugs and not currently prescribed for medication escalation. Oral anti-diabetic drugs are limited to one or more of the following: * Metformin * Sulfonylureas * Meglitinides * Thiazolidinediones 4. HbA1c \> 7.0% and \< 10% by local laboratory analysis. 5. Body Mass Index (BMI) ≥ 18 to ≤ 40.0 kg/m2. 6. Considered generally healthy upon completion of medical history, physical examination and bioc…
A General Electric LOGIQ E10 ultrasound machine with a C1-6-XD clear probe, will be used to selectively deliver pulsed ultrasound to both, the portal region of the liver and the superior mesenteric plexus.
Arctuva estimate
Verify or correct the compensation shown for this listing.